SageView Advisory Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$780K Sell
9,877
-799
-7% -$63.2K 0.03% 286
2025
Q3
$879K Sell
10,676
-776
-7% -$61.1K 0.03% 281
2025
Q2
$889K Sell
11,452
-215
-2% -$16.6K 0.03% 261
2025
Q1
$937K Sell
11,667
-605
-5% -$50.3K 0.04% 238
2024
Q4
$1M Buy
12,272
+374
+3% +$31.1K 0.04% 222
2024
Q3
$981K Sell
11,898
-941
-7% -$70.3K 0.05% 200
2024
Q2
$901K Buy
12,839
+8,022
+167% +$573K 0.04% 237
2024
Q1
$365K Sell
4,817
-12,345
-72% -$860K 0.02% 377
2023
Q4
$1.22M Buy
17,162
+580
+3% +$36.3K 0.05% 219
2023
Q3
$1.04M Sell
16,582
-3,592
-18% -$224K 0.06% 205
2023
Q2
$1.14M Buy
20,174
+110
+0.5% +$6.1K 0.06% 198
2023
Q1
$1.16M Buy
+20,064
New +$1.35M 0.07% 181

Other funds holding MET

SageView Advisory Group's MET Position: Q4 2025 in Review

SageView Advisory Group reduced its MetLife (MET) stake by 7.5% in Q4 2025, selling an estimated $63.2K and leaving 9,877 shares worth $780K. The position accounts for 0.03% of the portfolio, ranked #286.

SageView Advisory Group first reported a position in MET in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.22M in Q4 2023. 1,440 funds tracked by Wall St. Rank hold MET as of Q4 2025.

  • SageView Advisory Group held 9,877 shares of MetLife worth $780K as of Q4 2025.
  • SageView Advisory Group sold 799 MetLife shares in Q4 2025, an estimated $63.2K.
  • MetLife made up 0.03% of SageView Advisory Group's portfolio in Q4 2025, its #286 holding.
  • SageView Advisory Group first reported a position in MetLife in Q1 2023 and has held it in 12 quarters since.
  • SageView Advisory Group's MetLife position peaked at $1.22M in Q4 2023.
  • 1,440 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.